Alshajarah Hawra A, Alghamdi Hamza A, Alberi Zainab A, AlAam Fatima A, Alshajarah Abeer A, AlKhunaizi Maha F
School of Medicine, Xi'an Jiaotong University, Xi'an, CHN.
Medicine, King Fahad Medical City, Riyadh, SAU.
Cureus. 2022 Dec 26;14(12):e32946. doi: 10.7759/cureus.32946. eCollection 2022 Dec.
Peanut allergy has become more common among children and is considered one of the most common triggers for fatal anaphylaxis. Treatment of symptoms during a reaction is only one aspect of managing anaphylaxis; other elements include rigorous dietary avoidance and education about settings that could put the patient at a high risk of unintentional exposure. We aimed to review the prevalence, mechanism, diagnosis, treatment, and emergency action of peanut-induced anaphylaxis among children. We used a web-based literature search using the advanced features of databases such as PubMed, Scopus, Directory of Open Access Journals (DOAJ), Embase, Google Scholar, and Cochrane electronic databases. The most common food to cause fatal anaphylaxis and a common cause of food allergies is peanuts. Over the past two years, our knowledge improved more about peanut allergens, their prevalence, causes, diagnoses, and treatments. The research cited in this review demonstrates that the peanut allergens are most closely associated with disease differ across cultures, that early oral peanut exposure may reduce the occurrence of peanut allergy while early non-oral exposure may have the opposite effect, that complement activation by peanut constituents appears to promote peanut-induced anaphylaxis, and that oral immunotherapy, anti-IgE antibody, and a herbal formulation are all demonstrating promise as treatments. To conclude, peanut allergies have increased frequently during the past 10 years, especially in Westernized nations. Given that peanut allergy poses a danger for fatal anaphylaxis, response management is crucial. The current standard of care for those with nut allergies comprises complete food avoidance and the administration of injectable epinephrine to treat systemic symptoms.
花生过敏在儿童中变得越来越普遍,被认为是致命过敏反应最常见的诱因之一。过敏反应期间症状的治疗只是管理过敏反应的一个方面;其他要素包括严格避免食用花生以及对可能使患者面临意外接触高风险的环境进行教育。我们旨在综述儿童花生诱发过敏反应的患病率、机制、诊断、治疗及应急措施。我们利用基于网络的文献检索,使用了诸如PubMed、Scopus、开放获取期刊目录(DOAJ)、Embase、谷歌学术和考克兰电子数据库等数据库的高级功能。导致致命过敏反应最常见的食物以及食物过敏的常见原因是花生。在过去两年里,我们对花生过敏原、它们的患病率、病因、诊断和治疗有了更多了解。本综述引用的研究表明,花生过敏原与疾病的密切关联在不同文化中存在差异,早期口服花生可能会降低花生过敏的发生率,而早期非口服接触可能会产生相反的效果,花生成分激活补体似乎会促进花生诱发的过敏反应,并且口服免疫疗法、抗IgE抗体和一种草药配方都显示出有望成为治疗方法。总之,花生过敏在过去10年中频繁增加,尤其是在西方国家。鉴于花生过敏对致命过敏反应构成危险,应对管理至关重要。目前对坚果过敏者的标准治疗包括完全避免食用相关食物以及使用注射用肾上腺素治疗全身症状。